Literature DB >> 25082383

Cerebrospinal fluid levels of glial cell-derived neurotrophic factor correlate with spinal cord stimulation frequency in patients with neuropathic pain: a preliminary report.

K F McCarthy1, C McCrory2.   

Abstract

STUDY
DESIGN: Case series.
OBJECTIVES: To evaluate relationships between spinal cord stimulation (SCS) parameters and levels of glial cell-derived neurotrophic factor (GDNF).
SETTING: Ambulatory pain clinic of St James's Hospital, Dublin, Ireland.
METHODS: Nine patients with an implanted SCS and Failed Back Surgery Syndrome (FBSS) were administered the Brief Pain Inventory and Short Form (36) Health Survey. Following a lumbar puncture, levels of GDNF in cerebrospinal fluid (CSF) were assayed and correlated with stimulation parameters. Controls were patients with arthritic back pain who were matched for age, gender and SF-36 score.
RESULTS: Concentrations of GDNF in CSF are higher in patients with FBSS than controls (P=0.002) and correlate with SCS frequency (P=0.029).
CONCLUSION: Concentrations of GDNF in CSF are higher in neuropathic pain and appear to be related to stimulation frequency. Further work is needed to evaluate this potential relationship, both in neuropathic pain and in other contexts such as locomotor dysfunction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25082383     DOI: 10.1038/sc.2014.81

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  8 in total

1.  Evaluation of spinal cord stimulation on the symptoms of anxiety and depression and pain intensity in patients with failed back surgery syndrome.

Authors:  L P Robb; J M Cooney; C R McCrory
Journal:  Ir J Med Sci       Date:  2017-01-28       Impact factor: 1.568

2.  Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action.

Authors:  Jacob Caylor; Rajiv Reddy; Sopyda Yin; Christina Cui; Mingxiong Huang; Charles Huang; Rao Ramesh; Dewleen G Baker; Alan Simmons; Dmitri Souza; Samer Narouze; Ricardo Vallejo; Imanuel Lerman
Journal:  Bioelectron Med       Date:  2019-06-28

Review 3.  The Proteomics of Intrathecal Analgesic agents for Chronic Pain.

Authors:  David M Moore; Connail McCrory
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Spinal cord stimulation in experimental chronic painful diabetic polyneuropathy: Delayed effect of High-frequency stimulation.

Authors:  M van Beek; M van Kleef; B Linderoth; S M J van Kuijk; W M Honig; E A Joosten
Journal:  Eur J Pain       Date:  2016-11-28       Impact factor: 3.931

5.  Long-Term Spinal Cord Stimulation Alleviates Mechanical Hypersensitivity and Increases Peripheral Cutaneous Blood Perfusion in Experimental Painful Diabetic Polyneuropathy.

Authors:  Maarten van Beek; Denise Hermes; Wiel M Honig; Bengt Linderoth; Sander M J van Kuijk; Maarten van Kleef; Elbert A Joosten
Journal:  Neuromodulation       Date:  2018-03-09

Review 6.  Leptin and Associated Mediators of Immunometabolic Signaling: Novel Molecular Outcome Measures for Neurostimulation to Treat Chronic Pain.

Authors:  Thomas M Kinfe; Michael Buchfelder; Shafqat R Chaudhry; Krishnan V Chakravarthy; Timothy R Deer; Marc Russo; Peter Georgius; Rene Hurlemann; Muhammad Rasheed; Sajjad Muhammad; Thomas L Yearwood
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

7.  Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; Joanne Lysaght; Connail McCrory
Journal:  Brain Behav Immun Health       Date:  2020-12-07

Review 8.  Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome.

Authors:  Marco Echeverria-Villalobos; Justin Mitchell; Juan Fiorda-Diaz; Tristan Weaver
Journal:  J Pain Res       Date:  2021-07-30       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.